Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Financial guidance/ pros and cons:

I think the guidance that most of us (me anyway) are looking for is guidance based purely on fact, based on recent actual settlements and licenses. There is no hazzard here, or should I say the only hazzard is that the number will be too low because of events yet to unfold over the rest of the 4th qtr.

I'll be looking for an "update" on revenues in the associated PR, something of consequence in the "Subsequent Events" portion of the 10Q (which may be required), an EPS projection, or that ellusive footnote.

The above considered, there is a possibility (perhaps slim) that this 10Q will be a significant turning point, specifically for the PPS.

And other things could/will be announced/made public. Shares bought back, few if any warrants, Holocom, acquisition(s) progress, something new(?).

I'm hopeful. And I KNOW nuttin'!

SGE

Share
New Message
Please login to post a reply